drugset / Trial / NCT01340066
Safety and Efficacy Study of a New Treatment for Symptoms of Urinary Incontinence
Phase 1/2
Completed
94 enrolled
Beech Tree Labs, Inc.
Norwich Clinical Research Associates Ltd. · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine if a new drug treatment is effective for the treatment of symptoms of urinary incontinence.
Timeline
- Start
- 2011-04
- Primary completion
- 2012-05
- Completion
- 2012-05
Outcome
Missed primary endpoint
registry analysis (superiority or other test); Placebo vs UISH001; p = .92; Mean Difference (Final Values) 0; Chi-squared NCT01340066 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | UISH001 | Unknown | 1 unknown | Other |
Indications
No indication recorded.